CIK 0001439222
- Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $371,112
- in 2 filings, $371K under 10b5-1 plans
Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-05-27 | Scadden David Director | Grant or award · Stock option (right to buy) | +16,000 | 16,000 | ||
| 2017-05-25 | Cantley Lewis Clayton Jr. Director | Sale | −509 | $46.92 | $24K | 90,697 |
| 2017-05-25 | Cantley Lewis Clayton Jr. Director | Sale | −509 | $46.92 | $24K | 90,737 |
| 2017-05-24 | Cantley Lewis Clayton Jr. Director | Sale | −509 | $47.27 | $24K | 91,206 |
| 2017-05-24 | Cantley Lewis Clayton Jr. Director | Sale | −509 | $47.27 | $24K | 91,246 |
| 2017-05-01 | Schenkein David P Chief Executive Officer | Option exercise | +3,000 | $0.30 | $908 | 3,000 |
| 2017-05-01 | Schenkein David P Chief Executive Officer | Sale | −3,000 | $50.06 | $150K | 0 |
| 2017-05-01 | Schenkein David P Chief Executive Officer | Option exercise · Stock option (right to buy) | −3,000 | 192,656 | ||
| 2017-04-24 | Celgene European Investment Co LLC 10% owner | Purchase | +624,575 | $49.50 | $30.9M | 1,856,353 |
| 2017-04-18 | Cantley Lewis Clayton Jr. Director | Sale | −509 | $50.92 | $26K | 91,715 |
| 2017-04-18 | Cantley Lewis Clayton Jr. Director | Sale | −509 | $50.92 | $26K | 91,755 |
| 2017-04-17 | Cantley Lewis Clayton Jr. Director | Sale | −509 | $55.13 | $28K | 93,751 |
| 2017-04-17 | Cantley Lewis Clayton Jr. Director | Sale | −509 | $55.13 | $28K | 93,791 |
| 2017-04-17 | Cantley Lewis Clayton Jr. Director | Sale | −1,527 | $55.27 | $84K | 92,224 |
| 2017-04-17 | Cantley Lewis Clayton Jr. Director | Sale | −1,527 | $55.27 | $84K | 92,264 |
| 2017-04-03 | Biller Scott Chief Scientific Officer | Option exercise | +2,146 | $9.05 | $19K | 17,880 |
| 2017-04-03 | Biller Scott Chief Scientific Officer | Sale | −2,146 | $58.03 | $125K | 15,734 |
| 2017-04-03 | Biller Scott Chief Scientific Officer | Option exercise · Stock option (right to buy) | −2,146 | 46,011 | ||
| 2017-04-03 | Schenkein David P Chief Executive Officer | Option exercise | +3,000 | $0.30 | $908 | 3,000 |
| 2017-04-03 | Schenkein David P Chief Executive Officer | Sale | −3,000 | $58.62 | $176K | 0 |
Page 76 of 80 · 1,590 trades